Moran Slavin

Tel Aviv University, University of Central Florida

Papers

Total Citations

H-Index

About

Moran Slavin is a surgical researcher whose work centers on advancing minimally invasive and robotic-assisted procedures in complex gastrointestinal oncology. Her primary research areas include pancreatic and esophageal surgery, with a particular focus on optimizing perioperative outcomes and healthcare economics. Slavin’s major contribution lies in establishing evidence-based protocols for managing unplanned conversions during robotic pancreaticoduodenectomy—a high-stakes procedure where intraoperative complications can be life-threatening. Her 2023 study, with 17 citations, provides a stepwise approach to safe conversion, offering a practical framework that has been adopted by surgical teams seeking to reduce morbidity. Additionally, her 2024 cost-comparison analysis of robotic transhiatal esophagectomy between Medicare and private insurance highlights her commitment to evaluating the financial sustainability of advanced surgical technologies. By bridging technical safety with economic accountability, Slavin’s work informs both clinical decision-making and health policy. Her research is particularly valuable for surgeons and trainees navigating the complexities of robotic surgery, as it delivers actionable insights that improve patient outcomes while addressing systemic cost pressures.